| Volume: | 9,493,251 |
|---|---|
| Day's Low: | $55.12 |
| 52-wk Low: | $44.96 |
| Previous Close: | $56.06 |
| Dividend: | $0.00 |
| Market Cap: | 56,740,500 |
| Avg Volume: | 6,984,600 |
|---|---|
| Day's High: | $55.79 |
| 52-wk High: | $64.76 |
| Open Price: | $55.79 |
| Yield: | 0.00% |
| P/E (Forward): | 11.33 |
| 1:06 PM | 11/5/2009 | Amgen's Vectibix Misses Survival Goal,But Sales Could Benefit |
| 3:28 PM | 10/30/2009 | CORRECT: NY AG: 14 States, DC Sue Amgen Over Alleged Kickback Scheme |
| 3:03 PM | 10/30/2009 | AmerisourceBergen: Has Received Subpoena In Amgen Lawsuit-Fox Business |
| 8:53 AM | 10/22/2009 | UPDATE: BEFORE THE BELL -2: US HOT STOCKS TO WATCH |
| 6:30 AM | 10/22/2009 | BEFORE THE BELL -2: US HOT STOCKS TO WATCH |
| 2:43 PM | 10/19/2009 | 2nd UPDATE: FDA Delays Decision On Amgen Bone Drug |
| 11:02 AM | 10/19/2009 | UPDATE: FDA Delays Decision On Amgen Bone Drug For Added Info |
| Most Recent Quarter ($) | Same Quarter Last Year ($) | % Change | |
| EPS, Pro Forma | 1.49 | 1.21 | 23.14 |
| EPS, GAAP | 1.36 | 1.09 | 24.77 |
| Consensus Estimate | 1.25 | 1.06 | 17.92 |
| Trailing 12 Months | Year-Earlier Period | % Change | |
| EPS, Pro Forma | 4.88 | 4.48 | 8.93 |
| EPS, GAAP | 4.49 | 3.76 | 19.41 |
| Consensus Estimate | 4.57 | NA | NA |
| AMGN | Industry Average | |
| P/E (TTM) | 12.49 | 134.80 |
| P/E (Forward) | 11.33 | -20.50 |
| PEG Ratio | 1.05 | -1.03 |
| Price/Sales | 3.93 | 5.11 |
| Beta | 0.53 | 0.38 |